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ABSTRACT
The latex agglutination test (KAtex), direct agglutination test (DAT), and the rK39 immuno-chromato-
graphic strip test (dipstick test) were evaluated for their role in the diagnosis and prognosis of visceral leish-
maniasis (kala-azar) in India. Sera and urine samples from 455 subjects—150 confirmed visceral leishmani-
asis cases, 160 endemic controls, 100 non-endemic controls, and 45 other febrile diseases—were included 
in the study. The sensitivity of the KAtex, DAT, and rK39 strip test was 87% [95% confidence interval (CI) 
80-96], 93.3% (95% CI 88-100), and 98% (95% CI 93-100) respectively. The specificity of these tests was 
98% (95% CI 93-100), 93% (95% CI 87-100), and 89% (95% CI 82-97) for the KAtex, DAT, and rK39 strip 
test respectively. Fifty cases were followed up and subjected to the KAtex, DAT, and rK39 strip test after 30 
days of successful treatment. The DAT and rK39 strip test showed positive results in all the 50 cases whereas 
the KAtex showed no positive reaction in any case. Based on the results, it is concluded that the sensitivi- 
ty and specificity of the DAT and rK39 strip test are comparable but the greater convenience of use of the 
strip test makes it a better tool for the diagnosis of visceral leishmaniasis in the peripheral areas of endemic 
regions whereas the sensitivity of the KAtex needs to be improved to promote its use as a first-line diagnos-
tic test in the field-setting. It may be used for the prognosis of the disease as antigen becomes undetectable 
in urine after 30 days of the completion of the treatment. Alternatively, it can be used as an adjunct with 
rK39 for sero-epidemiological surveys.
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INTRODUCTION
Leishmaniasis is endemic in 88 countries spread 
over five continents, with an estimated yearly inci-
dence of 1-1.5 million cases of cutaneous leishman-
iasis and 500,000 cases of visceral leishmaniasis 
(VL). The number of people at risk is estimated to 
be 350 million, with an overall prevalence among 
12 million people (1). VL is a potentially-fatal dis- 
ease, caused by Leishmania donovani complex. Of all 
the VL cases, more than 90% are from India, Nepal, 
Bangladesh, southern Sudan, and northeast Brazil. 
For decades, the detection of the parasite has been 
considered to be the definitive diagnosis of this 
disease. It requires invasive procedure to find the 
parasite in the tissue, i.e. spleen, bone-marrow, 
and lymph-node. Although it is the gold standard 
for the diagnosis of VL, the procedure is cumber-
some, time-consuming, technically demanding, 
risky, and very difficult to apply in field condi-
tions or remote places/primary health centres. To 
obviate these procedures, various serological tests 
have been developed, evaluated, and tried. These 
tests have the advantage of being safe, are less in-
vasive, and can be carried out in large numbers of 
samples. Conventional methods of antibody de-
tection are immunodiffusion, complement fixa- 
tion test, indirect haemagglutination test, and 
countercurrent immunoelectrophoresis (2-4). 
However, aside from practical difficulties at pe-
ripheral laboratories, the sensitivities and speci-
ficities of most of the above tests have been the 
limiting factors.
Recently, quest for a simple diagnostic test for VL 
has led to the development of several novel tests, Singh DP et al. Ideal test for diagnosis of kala-azar
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such as direct agglutination test (DAT), rK39 dip-
stick assay, and latex agglutination test (KAtex) of 
urine. In particular, the development of different 
formats of DAT and its subsequent improvement 
has been an impetus to the improvement of di-
agnostic procedures of VL under field conditions 
(5-7). DAT is a sensitive test and well-adapted to 
screening larger populations, especially when using 
its variant referred to as fast agglutination screening 
test (8). However, data regarding its specificity in 
different populations and patient-groups are vari-
able, and many users of the test find it complicated 
to perform in remotely-located health facilities.
The rK39 dipstick assay—which is based on a cloned 
recombinant antigen of 39 amino acid repeats of 
a kinesin-like gene (9,10)—and the KAtex of urine 
latex agglutination test (11) have emerged as attrac-
tive options owing either to their simplicity (in the 
case of rK39 dipstick) or their high specificity (in the 
case of KAtex). A comparative evaluation of DAT, 
KAtex, and rK39 dipstick test was conducted aiming 
at obtaining more reliable estimates of their sensi-
tivity, specificity, and reproducibility in the field for 
the diagnosis and prognosis of VL in India.
MATERIALS AND METHODS
Patients were recruited at the Kala-azar Medical 
Research and Training Centre (KAMRC) in Muzaf-
farpur and Rajendra Memorial Research Institute 
(RMRI), Patna, Bihar, India. All clinically-suspected 
VL cases were subjected to parasitological examina-
tion. In total, 455 subjects—comprising 150 con-
firmed VL cases, 160 endemic controls, and 100 
non-endemic controls, and 45 other febrile diseas-
es—were included in the study. Sera and urine sam-
ples were collected. The cases were bled on the first 
encounter. The serum was separated and stored at 
-20 ºC till further use. However, the KAtex was done 
in fresh urine samples. The tests were carried out 
in duplicate in each patient’s sample with known 
positive and negative controls by a technical expert 
who had no knowledge about the patient’s data.
Reference standard
The cases presented with clinical symptoms and 
signs suggestive of kala-azar, i.e. fever of two weeks 
or more, splenomegaly (8.4±2.4 cm), and anaemia. 
Routine investigations were carried out to exclude 
other aetiologies of fever with hepato-splenomeg-
aly. The final diagnosis of VL was established by 
Karnofsky score, white blood cell (WBC) count, 
haemoglobin assay, and demonstration of parasites 
in splenic aspirates. 
Non-endemic controls included healthy persons 
from Europe and North America where kala-azar is 
not endemic. Endemic controls included healthy 
persons free of signs and symptoms of any disease, 
residing in same endemic area and are closely re-
lated to VL patients.
Latex agglutination test
The KAtex kit made in the USA was provided by 
Kalon Biological Limited (Sitting Bourne ME 98 AQ, 
UK)—lot no. K1-22 and Catalogue no. 5050-001. 
The test was conducted as per instructions of the 
manufacturers. Briefly, all reagents were brought 
to ambient temperature. The test latex was shaken 
well before use. Fifty mL of urine samples were 
heated by boiling for five minutes. Heat-treated 
urine samples were first allowed to cool to ambient 
temperature and then transferred to a glass-slide. 
Subsequently, the processed sample was mixed 
with a drop of test latex and stirred. The glass-slides 
were continuously rotated for two minutes before 
final reading of reactions. Positive reactions were 
determined by the degree of agglutination and re-
corded as 1+, 2+, and 3+. Appropriate positive and 
negative controls, supplied by the manufacturer, 
were included as test control.
Direct agglutination test
L. donovani (MHOM/IN/80/Dd8) obtained from 
the World Health Organization reference centre 
was used as antigen and prepared as per the meth-
od of Goyal et al. (12). Serum samples were serially 
two-fold diluted with saline and 0.2% gelatin so-
lution. Fifty mL of parasites suspension was added 
to an equal volume of diluted serum in each well. 
After the completion of the test, microtitre plates 
were shaken on a flat and smooth surface and were 
incubated at 22 °C overnight. The results were re-
corded in titres. The positive result was expressed as 
the highest dilution of serum that showed definite 
agglutination of parasite. Uniform mat formation 
suggested a positive result. A sample was considered 
positive if it had a titre of ≥1:3200 (cut-off value).
rK39 dipstick
The kit was provided by In Bios International, Inc. 
Seattle, Washington, DC, USA. The test was con-
ducted according to instructions of the manufac-
turer. The strip for VL assay is a qualitative mem-
brane-based immunoassay for the detection of 
antibodies to VL in human serum. In brief, 20 μL 
of serum was placed on pad. Following this, 2-3 
drops of wash buffer (provided) were added. The 
mixtures were carried up by capillary action of the 
membrane VL. The result was read within 10 min-
utes. The appearance of two pink lines—one con-
trol and one test—indicated a positive result while 
the appearance of one pink line (control) indicates 
that the test methodology is correct but sample is 
negative for antibodies.Singh DP et al. Ideal test for diagnosis of kala-azar
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Followed up cases
All the patients were provided a standard treatment 
with amphotericin B (Sarabhai Chemicals, Vado-
dara, India) in 1 mg/kg infusions on alternate days 
up to 15 infusions. After the completion of treat-
ment, the patients were free of symptoms. The hae-
matological parameters were restored. Fifty easily 
accessible (those who reported) among treated pa-
tients (n=150) were further followed up. Serum and 
urine samples were collected to know the prognos-
tic value of the rK39 dipstick test, DAT, and KAtex.
Statistical analysis
The serological data, thus, obtained were ana-
lyzed after entry in the Epi Info software (version 
6) and the SPSS package (version 16). The Fleiss 
quadratic method was used in calculating the con-
fidence interval of proportions. The sensitivity and 
specificity were mathematically calculated as fol-
lows: sensitivity=(true positive/true positive+false 
negative)x100; Specificity=(true negative/true 
negative+false positive)x100. 
Ethics
The Ethical Committee of the Institute of Medical 
Sciences, Banaras Hindu University, approved the 
study. Written consent was obtained from all the 
subjects.
RESULTS
Of the 150 parasitologically-proven index cases, 
131 (87%), 140 (93.3%), and 148 (98%) were posi-
tive for the KAtex, DAT, and rK39 strip test respec-
tively. Of the healthy controls (n=160), 2 (1.2%), 
5 (3.1%), and 17 (10.6%) showed positive reaction 
for the KAtex, DAT, and rK39 strip test respectively 
while none from the non-endemic area showed 
positive reaction. No cross reactivity was found be-
tween the VL cases and the other febrile cases. The 
table shows the results. 
The sensitivity of the KAtex, DAT, and rK39 strip 
test was 87% (95% CI 80-96), 93.3% (95% CI 88-
100), and 98% (95% CI 93-100) respectively. The 
specificity of these tests was 98% (95% CI 93-100), 
93% (95% CI 87-100), and 89% (95% CI 82-97) for 
the KAtex, DAT, and rK39 strip test respectively (Fig. 
1). Fifty clinically-cured cases were followed up and 
subjected to the KAtex, DAT and rK39 strip test af-
ter 30 days of successful treatment. The DAT and 
rK39 strip test showed positive results in all the 50 
(100%) cases whereas the KAtex showed no posi-
tive reaction in any case (Fig. 2).
Table. Comparison of KAtex, DAT, and rK39 strip test in patients with visceral leishmaniasis and controls
Clinical status No.
KAtex-positive  
      No.             %
DAT-positive 
       No.           %
rK39 strip test-positive
       No.                 %
Confirmed VL 150 131              87 140        93.3    148                 98
Non-endemic controls 100 0                 0 0             0     0                    0
Endemic controls 160   2               1.2  5           3.1      17                10.6
Other diseases 45 0                 0  0             0     0                    0
DAT=Direct agglutination test; KAtex=Latex agglutination test; VL=Visceral leishmaniasis
Fig. 2. Comparative evaluation of KAtex, DAT,







KAtex        DAT rK39
%
Positivity
DAT=Direct agglutination test; KAtex=Latex 
agglutination test
DISCUSSION
The present study was conducted on 455 subjects 
for the field evaluation of the KAtex, DAT and 
rK39 strip test as a diagnostic and prognostic tool 
for kala-azar. In this study, the DAT and rK39 strip 
test were evaluated on serum because the tests Singh DP et al. Ideal test for diagnosis of kala-azar
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were carried out in one-go. In clinical prac-
tice, however, these tests may be performed on 
whole fingerprick blood. In our study, the KAtex 
showed  87%  (95%  CI  80-96)  sensitivity.  These 
results corroborated well with the results of other 
researchers (13,14) who showed a sensitivity in the 
range of 87-95% where fresh urine samples were 
tested. However, the results do not corroborate 
with those of other studies (15-17) where poor sen-
sitivity has been reported, which may be due to low 
level of parasitaemia at a particular stage of disease 
or may be attributed to the effect of transport and 
subsequent storage of urine. Poor-to-moderate re-
producibility of the KAtex mentioned by other 
researchers (15,16) is an additional disadvantage 
of the test. On the other hand, our results on the 
specificity of the KAtex are consistent with those of 
previous studies which ranged from 98% to 100% 
(14-16). The positive KAtex by 1.2% (2 of 160) in 
the endemic controls points out to subclinical in-
fection, having a low level of parasitaemia. Subclin-
ical VL with a few or no symptoms with positive 
anti-leishmanial serology is documented (9). In 
this study, cut-off titre of ≥1:3,200 was employed 
for the DAT. Our results showed the sensitivity and 
specificity of 93.3% and 93% respectively. These 
results corroborated well with the results of other 
researchers (18-23). The rK39 strip test showed 98% 
sensitivity and 89% specificity. It showed negative 
reaction with the non-endemic controls whereas 
10.6% of the subjects from an endemic area were 
positive by the rK39 strip test; 10.6% positivity in 
the endemic controls but negative reaction with 
the non-endemic controls indicates false-positive 
reaction. False-positivity with serological tests is 
significantly higher than with the antigen test (KA-
tex). On the contrary, all the febrile cases showed 
non-reactive results by this method. This result cor-
roborated well with the finding of other researchers 
(24-26). The specificity of the test is lower because 
of the higher prevalence of subclinical or past infec-
tions. On the contrary, the study in Sudan showed 
lower sensitivity and specificity of this test (27). 
The reason for this difference in antibody response 
may be because of the ethnic differences or the dif-
ference in antibody response. 
In the present study, 50 successfully-treated indi-
viduals were followed up to evaluate the prognostic 
value of the KAtex, DAT, and rK39 strip test after 30 
days of the completion of treatment. All showed 
positive reaction for the rK39 strip test and DAT, 
which indicates persistence of antibodies whereas 
the KAtex showed no positive reaction, indicating 
absence of antigens in urine. These observations 
were supported in various studies performed in suc-
cessfully-treated cases (26,28-30).
If we compare the overall yield of these diagnostic 
tests, the DAT and rK39 strip test are comparable. 
The advantage of DAT includes the availability of 
titres; however, the procedure for the DAT is cum-
bersome and requires incubation, and the storage 
of antigen also requires a cold-chain. This may not 
be possible in remote rural India. By contrast, the 
rK39 strip test procedure is easy, simple, and user-
friendly and can be easily performed and inter-
preted in most peripheral areas even by an auxil-
iary health worker. Thus, the rK39 strip test has the 
potential to be used as a suitable candidate for the 
diagnosis of VL whereas the prognostic value of the 
KAtex seems to be promising.
The study was carried out only in a limited number 
of post-treated kala-azar cases. For the correct as-
sessment of these tests, more number of cases with 
well-matched controls may be carried out to reach 
a definite conclusion. However, with these obser-
vations, it may be concluded that the rK39 strip 
test might be used as a diagnostic tool for kala-azar. 
Since this is a highly-sensitive test, an ideal format 
for use under field conditions, quick and no special 
equipment is needed. For monitoring successful 
treatment, the KAtex may be used because anti-
gen becomes undetectable in urine after successful 
treatment. For sero-epidemiological studies, both 
rK39 and KAtex may be carried out. Their simplici- 
ty and detection of both antigen and antibodies 
may give better information on the disease preva-
lent in a particular area.
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